Further Clarification on news item
With reference to the news flashed on ET NOW, January 13, 2016 - "Marksans Pharma Goa plant get notification of deficiency in GMP from UK MHRA. 40% of Marksans Pharma revenue comes from UK", Marksans Pharma Ltd has submitted to BSE a copy of further Clarification is enclosed. Marksans Pharma tanks over 15% on heavy volumes
Since January 12, the stock plunged 33% after the media report suggests that the company's Goa plant get notification of deficiency in GMP from UK MHRA. Marksans Pharma's Goa Plant Under UK Regulator Scanner
Marksans Pharma on Wednesday said UK health regulator has issued "certain observations" regarding the company's Goa facility, after inspecting it in November. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Marksans Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Clarifies on News Item
With reference to the news flashed on ET NOW, January 13, 2016 - "Marksans Pharma Goa plant get notification of deficiency in GMP from UK MHRA. 40% of Marksans Pharma revenue comes from UK", Marksans Pharma Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Marksans Pharma Ltd
The Exchange has sought clarification from Marksans Pharma Ltd with reference to the news flashed on ET NOW, January 13, 2016 - "Marksans Pharma Goa plant get notification of deficiency in GMP from UK MHRA. 40% of Marksans Pharma revenue comes from UK".The reply is awaited. Disclosure under Reg. 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Marksans Pharma Ltd has informed BSE regarding Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Financial Results with Results Press Release & Limited Review Report for Sept 30, 2015
Marksans Pharma Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2015. Shareholding Pattern for September 30, 2015
Marksans Pharma Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Updates on Outcome of AGM
Marksans Pharma Ltd has submitted to BSE a copy of Minutes of the 23rd Annual General Meeting (AGM) of the Company held on September 29, 2015.